Cite
HARVARD Citation
Soubrier, M. et al. (n.d.). AB1333 Retention rates of adalimumab, etanercept, and infliximab as biotherapies for rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis patients in daily practice in auvergne (FRANCE). Annals of the rheumatic diseases. p. 1756. [Online].